Stay updated on Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    IPD (Individual Participant Data) data-sharing plan added and related terminology updated. Study Protocol and Statistical Analysis Plan are now linked, and MeSH terms and record history metadata expanded to improve indexing and transparency of the trial record.
    Difference
    78%
    Check dated 2026-08-01T20:33:28.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision tag (Revision: v3.6.4) is shown, and several non-core study documents/listings were removed from the study record, reflecting a documentation cleanup on the page.
    Difference
    21%
    Check dated 2026-07-25T17:44:05.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.2 to v3.6.3, reflecting a newer version of the page content. The change does not modify displayed study information.
    Difference
    0.0%
    Check dated 2026-07-04T12:53:51.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the study documents or page metadata.
    Difference
    0.0%
    Check dated 2026-06-27T05:41:44.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Recruitment status on the study page has been updated to indicate that no participants are being sought. New help/guide sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label was adjusted along with a revision notice (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T04:39:14.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The revision label now shows v3.5.5, replacing the previous v3.5.4. This signals that the page has been updated to a newer version.
    Difference
    0.0%
    Check dated 2026-06-05T21:43:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page.